-
Symbol
-
SYRS on Nasdaq
-
Investment type
-
Equity / Common Stock, $0.001 par value
-
Latest Disclosed Shares Owned
-
1,063,829 shares
-
Security Ownership %
-
3.8%
Invus Public Equities, L.P. ownership in Syros Pharmaceuticals, Inc. Common Stock, $0.001 par value (SYRS)
12 Feb 2025 - Invus Public Equities, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,063,829 shares of Syros Pharmaceuticals, Inc. Common Stock, $0.001 par value (SYRS).
This represents 3.8% ownership of the company.
This is the first filing by Invus Global Management, LLC disclosing ownership of Syros Pharmaceuticals, Inc. Common Stock, $0.001 par value (SYRS).